Nn9536-7545
Research payments
$4,497,019
Through program year 2025, $4,497,019 in research payments was reported against Nn9536-7545, across 14,374 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $412,143 | 73 |
| 2024 | Research | $1,551,502 | 1,702 |
| 2023 | Research | $2,514,520 | 10,665 |
| 2022 | Research | $18,854 | 1,934 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ildiko Lingvay Dallas, TX Named on 836 payments
- Julio Rosenstock Dallas, TX Named on 776 payments
- Juan Frias San Diego, CA Named on 733 payments
- John Buse Chapel Hill, NC Named on 698 payments
- John Vanderzyl Sugar Land, TX Named on 681 payments
- Bradley Block Oviedo, FL Named on 633 payments
- Matthew Lewis Aurora, CO Named on 612 payments
- William Garvey Birmingham, AL Named on 594 payments
- John Scott Glen Allen, VA Named on 551 payments
- Mark Christiansen Walnut Creek, CA Named on 532 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.